Clinical Trial Update: Prevention of Clostridium Difficile-associated Diarrhea by Daily Intake of Kefir [Phase 2]

View source ↗

Summary

Phase 2 trial assessing daily kefir intake to prevent Clostridium difficile-associated diarrhea; study terminated with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection
• Diarrhea

Drugs mentioned

• Kefir (daily intake)

Snippet

Sponsor: St. Luke's Hospital of Duluth | Conditions: Clostridium Difficile Infection, Diarrhea | Phase 2 | Status: TERMINATED | Results posted: 2022-05-19